SCOPUS 정보 검색 플랫폼

Volumn 109, Issue 4, 2012, Pages 576-580

Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute of Japan candesartan randomized trial for evaluation in coronary artery disease [HIJ-CREATE] substudy)

(5) Sugiura, Ryo a Ogawa, Hiroshi b Oka, Toshiaki a Koyanagi, Ryo b Hagiwara, Nobuhisa b

a SEIREI HAMAMATSU GENERAL HOSPITAL (Japan)

b TOKYO WOMEN'S MEDICAL UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SEX FACTORS; TETRAZOLES;

EID: 84856439171 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2011.09.050 Document Type: Article

Times cited : (15)

References (12)

1
- 77954030665
- Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials
- I. Sipahi, S.M. Debanne, D.Y. Rowland, D.I. Simon, J.C. Fang Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials Lancet Oncol 11 2010 627 636
- (2010) Lancet Oncol , vol.11 , pp. 627-636
- Sipahi, I.¹ Debanne, S.M.² Rowland, D.Y.³ Simon, D.I.⁴ Fang, J.C.⁵

2
- 78650703447
- Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials
- S. Bangalore, S. Kumar, S.E. Kjeldsen, H. Makani, E. Grossman, J. Wetterslev, A.K. Gupta, P.S. Sever, C. Gluud, F.H. Messerli Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials Lancet Oncol 12 2011 65 82
- (2011) Lancet Oncol , vol.12 , pp. 65-82
- Bangalore, S.¹ Kumar, S.² Kjeldsen, S.E.³ Makani, H.⁴ Grossman, E.⁵ Wetterslev, J.⁶ Gupta, A.K.⁷ Sever, P.S.⁸ Gluud, C.⁹ Messerli, F.H.¹⁰

3
- 79955560688
- Use of angiotensin receptor blockers and the risk of cancer
- B. Pasternak, H. Svanstrm, T. Callrus, M. Melbye, A. Hviid Use of angiotensin receptor blockers and the risk of cancer Circulation 123 2011 1729 1736
- (2011) Circulation , vol.123 , pp. 1729-1736
- Pasternak, B.¹ Svanstrm, H.² Callrus, T.³ Melbye, M.⁴ Hviid, A.⁵

4
- 79952773620
- Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension
- C.C. Huang, W.L. Chan, Y.C. Chen, T.J. Chen, S.J. Lin, J.W. Chen, H.B. Leu Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension Am J Cardiol 107 2011 1028 1033
- (2011) Am J Cardiol , vol.107 , pp. 1028-1033
- Huang, C.C.¹ Chan, W.L.² Chen, Y.C.³ Chen, T.J.⁴ Lin, S.J.⁵ Chen, J.W.⁶ Leu, H.B.⁷

5
- 66249127233
- Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)
- HIJ-CREATE Investigators
- H. Kasanuki, N. Hagiwara, S. Hosoda, T. Sumiyoshi, T. Honda, K. Haze, M. Nagashima, J. Yamaguchi, H. Origasa, M. Urashima, H. Ogawa HIJ-CREATE Investigators Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE) Eur Heart J 30 2009 1203 1212
- (2009) Eur Heart J , vol.30 , pp. 1203-1212
- Kasanuki, H.¹ Hagiwara, N.² Hosoda, S.³ Sumiyoshi, T.⁴ Honda, T.⁵ Haze, K.⁶ Nagashima, M.⁷ Yamaguchi, J.⁸ Origasa, H.⁹ Urashima, M.¹⁰ Ogawa, H.¹¹

6
- 0032543880
- Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
- DOI 10.1016/S0140-6736(98)03228-0
- A.F. Lever, D.J. Hole, C.R. Gillis, I.R. McCallum, G.T. McInnes, P.L. MacKinnon, P.A. Meredith, L.S. Murray, J.L. Reid, J.W. Robertson Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352 1998 179 184 (Pubitemid 28327802)
- (1998) Lancet , vol.352 , Issue.9123 , pp. 179-184
- Lever, A.F.¹ Hole, D.J.² Gillis, C.R.³ McCallum, I.R.⁴ McInnes, G.T.⁵ MacKinnon, P.L.⁶ Meredith, P.A.⁷ Murray, L.S.⁸ Reid, J.L.⁹ Robertson, J.W.K.¹⁰

7
- 0036290279
- Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
- DOI 10.1016/S0006-291X(02)00496-5, PII S0006291X02004965
- M. Fujita, I. Hayashi, S. Yamashina, M. Itoman, M. Majima Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis Biochem Biophys Res Commun 294 2002 441 447 (Pubitemid 34694114)
- (2002) Biochemical and Biophysical Research Communications , vol.294 , Issue.2 , pp. 441-447
- Fujita, M.¹ Hayashi, I.² Yamashina, S.³ Itoman, M.⁴ Majima, M.⁵

8
- 85047693609
- Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth
- DOI 10.1172/JCI200316645
- K. Egami, T. Murohara, T. Shimada, K. Sasaki, S. Shintani, T. Sugaya, M. Ishii, T. Akagi, H. Ikeda, T. Matsuishi, T. Imaizumi Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth J Clin Invest 112 2003 67 75 (Pubitemid 38056377)
- (2003) Journal of Clinical Investigation , vol.112 , Issue.1 , pp. 67-75
- Egami, K.¹ Murohara, T.² Shimada, T.³ Sasaki, K.-I.⁴ Shintani, S.⁵ Sugaya, T.⁶ Ishii, M.⁷ Akagi, T.⁸ Ikeda, H.⁹ Matsuishi, T.¹⁰ Imaizumi, T.¹¹

9
- 0036681694
- Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis
- A. Miyajima, T. Kosaka, T. Asano, T. Asano, K. Seta, T. Kawai, M. Hayakawa Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis Cancer Res 62 2002 4176 4179 (Pubitemid 34830392)
- (2002) Cancer Research , vol.62 , Issue.15 , pp. 4176-4179
- Miyajima, A.¹ Kosaka, T.² Asano, T.³ Asano, T.⁴ Seta, K.⁵ Kawai, T.⁶ Hayakawa, M.⁷

10
- 79952774764
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
- K.K. Teo, P. Sleight, P. Gao, S. Yusuf Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals J Hypertens 29 2011 623 635
- (2011) J Hypertens , vol.29 , pp. 623-635
- Teo, K.K.¹ Sleight, P.² Gao, P.³ Yusuf, S.⁴

11
- 80051660023
- Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: A nationwide case-control study
- C.H. Chang, J.W. Lin, L.C. Wu, M.S. Lai Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study J Clin Oncol 29 2011 3001 3007
- (2011) J Clin Oncol , vol.29 , pp. 3001-3007
- Chang, C.H.¹ Lin, J.W.² Wu, L.C.³ Lai, M.S.⁴

12
- 78650791243
- Cancer incidence and incidence rates in Japan in 2005: Based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project
- Japan Cancer Surveillance Research Group
- T. Matsuda, T. Marugame, K. Kamo, K. Katanoda, W. Ajiki, T. Sobue Japan Cancer Surveillance Research Group Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project Jpn J Clin Oncol 41 2011 139 147
- (2011) Jpn J Clin Oncol , vol.41 , pp. 139-147
- Matsuda, T.¹ Marugame, T.² Kamo, K.³ Katanoda, K.⁴ Ajiki, W.⁵ Sobue, T.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.